Applied Biosystems/MDS SCIEX Celebrates Year of Innovation at Press Conference and Events at the American Society of Mass Spectrometry Annual Conference; Applied Biosystems to Webcast News Conference.FOSTER CITY, Calif. & SAN ANTONIO -- To commemorate an unprecedented number of new mass spectrometry-based product introductions, Applied Biosystems Group (NYSE NYSE See: New York Stock Exchange :ABI Abi (ā`bī) [short for Abijah], in the Bible, King Hezekiah's mother. (Application Binary Interface) A specification for a specific hardware platform combined with the operating system. ), an Applera Corporation business, together with its joint venture partner MDS MDS, n See temporomandibular pain-dysfunction syndrome. MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there Sciex, a division of MDS Inc. (NYSE:MDZ MDZ Mendez MDZ Moskauer Deutsche Zeitung (Moscow German newspaper) MDZ Maritime Defense Zone MDZ Musik Der Zukunft (music label & community) MDZ Mendoza, Mendoza, Argentina - El Plumerillo )(TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension :MDS), will host a news conference for media and financial analysts to discuss four recently introduced mass spectrometers and the potential impact that these systems may have on life science research, drug discovery and development, protein biomarker research, food and environmental testing, and forensic analysis. The news conference is scheduled to take place on Monday, June 6, 2005, at 11:00 a.m. CDT CDT abbr. Central Daylight Time CDT Central Daylight Time CDT n abbr (US) (= Central Daylight Time) → hora de verano del centro; (BRIT in Media Room 205 at the Henry B. Gonzalez Convention Center The Henry B. Gonzalez Convention Center is located in downtown San Antonio along the banks of the San Antonio River Walk. The facility is the central component of the city’s successful convention industry. The center, named for the late US congressman Henry B. in conjunction with the 53rd Annual Conference of the American Society of Mass Spectrometry mass spectrometry or mass spectroscopy Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields. (ASMS ASMS American Society for Mass Spectrometry ASMS Association of Salaried Medical Specialists ASMS Advanced Satellite Mobile Systems ASMS Alabama School of Mathematics and Science ASMS American Society for Mohs Surgery ASMS Arkansas School for Math and Science ), in San Antonio, TX, U.S.A., June 5-9, 2005. This news conference will be webcast. Applied Biosystems/MDS SCIEX Annual Users Meeting Drawing approximately 1,000 attendees annually, the Applied Biosystems/MDS SCIEX annual users meeting will be held on Sunday, June 5, 2005, from 9:00 a.m. - 3:00 p.m. CDT in Ballroom A at the convention center. At the users meeting, leaders from industry and academia, as well as scientists from Applied Biosystems and MDS Sciex, will discuss advanced workflows for DMPK DMPK Drug Metabolism and Pharmacokinetics DMPK Dystrophia Myotonica Protein Kinase (1) studies, protein biomarker discovery and validation, and the application of mass spectrometry in food safety testing, environmental analysis, and clinical research. Invited speakers include Roland S. Annan, Ph.D., of GlaxoSmithKline Inc., K.W. Michael Siu, Ph.D., of York University, Russell Grant, Ph.D., Esoterix Inc., and Kelvin Lee, Ph.D., of Cornell University. To register for the users meeting and see a detailed agenda, please visit http://info.appliedbiosystems.com/asms. This meeting will not be webcast. At both events, Applied Biosystems/MDS SCIEX will feature several of its new products that have commanded the attention of the life sciences mass spectrometry marketplace over the past several months: --API 5000(TM) LC/MS/MS System, the most sensitive, commercially available mass spectrometer for small molecule quantification; --API 3200(TM) and 3200 Q TRAP(R) LC/MS/MS Systems, high-value triple quardupole and hybrid triple quadrupole A quadrupole is one of a sequence of configurations of electric charge or gravitational mass that can exist in ideal form, but it is usually just part of a multipole expansion of a more complex structure reflecting various orders of complexity. linear ion trap systems, designed for food and beverage F&B is a common abbreviation in the United States and Commonwealth countries, including Hong Kong. F&B is typically the widely accepted abbreviation for "Food and Beverage," which is the sector/industry that specializes in the conceptualization, the making of, and delivery of foods. , environmental, forensic, clinical research, proteomics, and pharmaceutical analysis markets; --4800 MALDI MALDI Matrix-Assisted Laser Desorption/Ionization TOF/TOF(TM) Analyzer, the most sensitive, commercially available MALDI TOF/TOF(TM) mass spectrometer for identifying and quantifying protein biomarkers; --BIOiTRAQ(TM) Systems, an integration of innovative Applied Biosystems/MDS SCIEX mass spectrometry platforms, novel reagent chemistries, such as iTRAQ(TM) and ICAT ICAT Isotope-Coded Affinity Tagging ICAT Intelligent Computer-Assisted Training ICAT International Centre for Automotive Technology (Gurgaon, India) ICAT International Convention Against Torture ICAT International Cat Agility Tournament (R) reagents, and advanced LC separation systems developed for automated workflows in biomarker discovery and validation; and --MarkerView(TM) Software, a new software package for metabolomics and biomarker profiling analysis that allows researchers to mine complex mass spectrometry data sets for changes in metabolic and proteomic patterns resulting from conditions such as disease, drug treatment, or drug toxicity. "The Applied Biosystems/MDS SCIEX joint venture's continued focus on innovation for mass spectrometry is clearly evidenced by this impressive number of new product introductions," said Laura Lauman, Division President of the Proteomics and Small Molecule Business for Applied Biosystems. "We expect to build on our leadership position by continuing to develop additional leading-edge technologies that address both market and user needs," said Andy Boorn, President of MDS Sciex. Press Conference Webcast Details and Other Events Presentations from Applied Biosystems and MDS Sciex management will cover a broad range of products for small molecule analysis and proteomics, and company-related highlights. Additionally, Phil Andrews, Ph.D., of the University of Michigan (body, education) University of Michigan - A large cosmopolitan university in the Midwest USA. Over 50000 students are enrolled at the University of Michigan's three campuses. The students come from 50 states and over 100 foreign countries. and Zong-Ping Zhang, Ph.D., of PPD (1) (Parallel Presence Detect) The method used by earlier SIMM memory modules to communicate their capacity to the computer. A binary number coming from a parallel set of pins was read by the system, with each pin representing one bit. Contrast with SPD. Inc., a discovery and development services and products provider for pharmaceutical, biotechnology, and medical device companies, will discuss the applications of new mass spectrometry technology in current biological and drug discovery research. Interested media, customers, and investors who wish to view the webcast of the news conference should visit http://ir.appliedbiosystems.com/ and go to the presentations page within the Investor Relations Investor relations The process by which the corporation communicates with its investors. web site. The news conference will also be archived on this page. To listen to the meeting by telephone, dial 706-634-4992 (code "Applied Biosystems news conference") between 10:45 a.m. and 11:00 a.m. CDT. An audio replay of the news conference will be available two hours after completion until June 20, 2005. To access the replay, dial 706-645-9291 and enter conference ID 6628875. Afternoon Workshops Following the users meeting, Applied Biosystems/MDS SCIEX will host of series of afternoon workshops on June 5, 2005, from 3:30-5:00 p.m. CDT covering the latest advances in mass spectrometry, software, and workflows. Seating is limited and pre-registration is recommended at http://info.appliedbiosystems.com/asms. --Applied Biosystems/MDS SCIEX Software: Integration into the Lab Environment. This workshop will cover scenarios for the use of new functionality in Analyst(R) Software v.1.4.1. A preview of future Applied Biosystems/MDS SCIEX software which allows customized workflows in the lab environment will also be presented. --Protein Identification and Expression Software and Workflows for the Biologist. This workshop will demonstrate new protein identification and expression software features and various workflows for LC/MS/MS, MALDI, and LC/MALDI analysis. --MALDI MS Imaging: Software and Sample Preparation. Leading researchers in the field of MALDI mass spectrometry imaging Mass spectrometry imaging (also known as imaging mass spectrometry) is a technique used in mass spectrometry to visualize the spatial distribution of e.g. compounds, biomarker, metabolites, peptides or proteins by their molecular masses. will present their latest results. In addition, new techniques in sample preparation, data acquisition, and data processing will be discussed. Lunchtime Seminar On Wednesday, June 8, 2005, from 12:15-1:30 p.m. CDT in Room 202A, Applied Biosystems/MDS SCIEX and Dionex will host a lunchtime seminar entitled "The Theory and Application of Ion Chromotography coupled with MS/MS MS/MS Tandem Mass Spectroscopy MS/MS Multistage Mass Spectrometry Detection for the Analysis of Emerging Environmental Contaminants." To register or request more information, please email Lynda.Hammett@appliedbiosystems.com and reference "AB/Dionex ASMS" in the subject line of the email. In addition, Applied Biosystems/MDS SCIEX and its collaborators will present data on mass spectrometry research in more than 100 scientific oral and poster presentations during the ASMS conference. These data are focused on a wide range of topics, including: --Drug metabolism and pharmacokinetics --Small molecule quantitation --Metabolite identification --Biomarker identification and validation --Metabolomics --Environmental applications --Clinical research --Food & beverage testing --Forensic analysis --Advances in proteomics About Applera Corporation and Applied Biosystems Applera Corporation consists of two operating groups. The Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids Nucleic acids The cellular molecules DNA and RNA that act as coded instructions for the production of proteins and are copied for transmission of inherited traits. (DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. and RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic ), small molecules, and proteins to make scientific discoveries, develop new pharmaceuticals, and conduct standardized testing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.7 billion during fiscal 2004. The Celera Genomics Group (NYSE:CRA See Community Reinvestment Act. ) is engaged principally in the discovery and development of targeted therapeutics for cancer, autoimmune and inflammatory diseases. Celera Genomics is leveraging its proteomic, bioinformatic, and genomic capabilities to identify and validate drug targets, and to discover and develop small molecule therapeutics. It is also seeking to advance therapeutic antibody and selected small molecule drug programs in collaboration with global technology and market leaders. Celera Diagnostics, a 50/50 joint venture between Applied Biosystems and Celera Genomics, is focused on discovery, development, and commercialization of diagnostic products. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.applera.com, or by telephoning 800-762-6923. Information about Applied Biosystems is available at http://www.appliedbiosystems.com/. About MDS Sciex and MDS Inc. MDS Sciex is the analytical instrumentation and technology solutions division of MDS Inc. MDS Inc. has more than 9,000 highly skilled people in 25 countries. We provide a diverse range of superior products and services to increase our customers' speed, precision and productivity in the drug development and disease diagnosis processes. We are a global, values-driven health and life sciences company, recognized for our reliability and collaborative relationships as we help create better outcomes in the treatment of disease. Find out more at www.mdsintl.com or by calling 1-888-MDS-7222, 24 hours a day. Applied Biosystems Forward Looking Statement Certain statements in this press release are forward-looking and subject to a variety of risks and uncertainties. These may be identified by the use of forward-looking words or phrases such as "should" and "expect," among others. These forward-looking statements are based on Applera Corporation's current expectations. The Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 provides a "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " for such forward-looking statements. In order to comply with the terms of the safe harbor, Applera Corporation notes that a variety of factors could cause actual results and experience to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. These risk factors include but are not limited to (1) rapidly changing technology and dependence on development and customer acceptance of new products; (2) sales dependent on customers' capital spending capital spending Spending for long-term assets such as factories, equipment, machinery, and buildings that permits the production of more goods and services in future years. policies and government-sponsored research; (3) claims for patent infringement; and (4) other factors that might be described from time to time in Applera Corporation's filings with the Securities and Exchange Commission. All this information in this press release is as of the date of the release, and Applera does not undertake any duty to update this information, including any forward-looking statements, unless required by law. For research use only. Not for use in diagnostics procedures. Applera, BIOiTRAQ, Celera Diagnostics and iTRAQ are trademarks and Applied Biosystems and Celera are registered trademarks of Applera Corporation or its subsidiaries in the U.S. and/or certain other countries. API 3200, API 5000, MALDI TOF/TOF, MarkerView, and TOF/TOF are trademarks and Analyst and Q TRAP are registered trademarks of Applied Biosystems/MDS SCIEX, a joint venture between Applera Corporation and MDS Inc. ICAT is a registered trademark of the University of Washington and is exclusively licensed to the Applied Biosystems Group of Applera Corporation. All other trademarks are the sole property of their respective owners. Copyright(C) 2005. Applera Corporation and MDS Inc. All rights reserved. Information subject to change without notice. (1) Drug metabolism and pharmacokinetics |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion